To summarize, the results of this study indicate that CYP2C8, CYP2C9, and CYP2C19 present potential serum biomarkers for the early diagnosis of HCC and combination analysis showed significant interactions that were better prognostic indicators of HCC. This evidence concerns the gene CYP2C19 and hepatocellular carcinoma.